Company intelligence / Profile preview

Thread Bioscience

Bethlehem, Pennsylvania, United Statesthreadb.com ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

Thread Bioscience has developed and commercialized two main products—CultureStat, a rapid point-of-care test for urinary tract infections using spectrophotometry and computer science to detect bacterial growth, and SentiLiter, a wireless sensor-based system for remote measurement of patient fluid intake/output. Both products are designed to improve efficiency in healthcare delivery by providing actionable data at the point of care. No clinical trial results are referenced as these are medical devices rather than therapeutics.

Therapeutic areas: NephrologyInfectious Diseases
Modalities: Device (Point-of-care diagnostic device)Device (Remote patient monitoring system)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Thread Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thread Bioscience.

Explore the full profile